|
AURKA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.421000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.441100E-03 |
| Normal-vs-Stage2 |
2.078000E-02 |
| Normal-vs-Stage3 |
3.157900E-03 |
| Normal-vs-Stage4 |
4.115100E-03 |
| Stage1-vs-Stage2 |
6.843000E-01 |
| Stage1-vs-Stage3 |
5.040200E-01 |
| Stage1-vs-Stage4 |
4.702400E-01 |
| Stage2-vs-Stage3 |
4.017400E-01 |
| Stage2-vs-Stage4 |
3.475800E-01 |
| Stage3-vs-Stage4 |
8.492600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.256800E-03 |
| Normal-vs-AfricanAmerican |
1.519170E-03 |
| Normal-vs-Asian |
5.283300E-03 |
| Caucasian-vs-AfricanAmerican |
2.987800E-01 |
| Caucasian-vs-Asian |
7.496800E-01 |
| AfricanAmerican-vs-Asian |
3.771800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.161400E-03 |
| Normal-vs-Female |
2.917000E-03 |
| Male-vs-Female |
5.602600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.221790E-02 |
| Normal-vs-Age(41-60Yrs) |
1.970640E-04 |
| Normal-vs-Age(61-80Yrs) |
3.188400E-02 |
| Normal-vs-Age(81-100Yrs) |
7.478800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.619500E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.620400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.225200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.655680E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.041230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.035410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.279200E-01 |
| Classical-VS-Follicular |
8.929800E-01 |
| Classical-VS-Other |
4.203000E-01 |
| Classical-VS-Normal |
4.355600E-03 |
| Tall-VS-Follicular |
9.048800E-01 |
| Tall-VS-Other |
3.667800E-01 |
| Tall-VS-Normal |
1.696000E-02 |
| Follicular-VS-Other |
4.423000E-01 |
| Follicular-VS-Normal |
5.963300E-03 |
| Other-VS-Normal |
2.402300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.422300E-03 |
| Normal-vs-N1 |
3.635000E-04 |
| N0-vs-N1 |
1.000760E-01 |
|
|
